What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma

Hematologic Oncology Update

English - October 09, 2023 17:02 - 47 minutes - 27.3 MB - ★★★★★ - 67 ratings
Science Health & Fitness Medicine cancer hematologic oncology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Oncology Today with Dr Neil Love: Blastic Plasmacytoid Dendritic Cell Neoplasm

Next Episode: Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar

Prof Philippe Moreau from the University Hospital of Nantes in France discusses anti-CD38 antibody-based treatment approaches for newly diagnosed and relapsed/refractory multiple myeloma, moderated by Dr Neil Love.